fashion -WSS

fashion

author：entertainment 2025-09-27 23:33:26 - browse：537

Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to improve muscle function compared to a placebo in a large clinical trial — likely a major disappointment for patients and doctors who have been desperately awaiting the treatment for years.

The company said all patients in the study improved and that secondary measurements indicated the drug was having an effect. Nevertheless, the results are likely to raise questions about whether the Food and Drug Administration will expand access to the medicine.

Trading in Sarepta shares was halted at $107 with the release of the study results.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Organ transplantation is at a crossroads. Major reform is needed

entertainment

knowledge

WSS

Did you have Obamacare on your GOP debate bingo card?

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

HIPAA doesn't protect reproductive records from prosecutors

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

FDA official pushes for dedicated emerging pathogens team

focus

fashion

focus

The high cost of giving birth even with insurance

Inequities make cancer less preventable for women: report

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Did you have Obamacare on your GOP debate bingo card?

Apple is now the first public company to be valued at $3 trillion

AbbVie dramatically boosts its spending on lobbying

The cancer drug shortage isn’t new — and neither are the solutions

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Medical records are filled with copy

FDA advisers vote against ALS treatment from BrainStorm

hotspot

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Organ transplantation is at a crossroads. Major reform is needed

Mindstrong's demise and the future of mental health care

Ionis has late

Review: 'Barbie' will hit you like a shot in the heart

entertainment

hotspot

knowledge

hotspot